Shuttle Pharmaceuticals Holdings Inc (SHPH) is not a good buy for a beginner investor with a long-term strategy at this time. The company's financial performance is weak, with significant declines in net income and EPS. Technical indicators show bearish trends, and there are no positive trading signals or catalysts to support a strong entry point. Additionally, there is no recent news, analyst ratings, or influential trading activity to suggest a compelling reason to invest.
The MACD is positive but contracting, indicating a lack of strong momentum. RSI is neutral at 33.896, and moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading below key pivot levels, with support at 0.869 and resistance at 1.031, suggesting limited upside potential in the short term.
NULL identified. No recent news or significant trading activity from hedge funds, insiders, or Congress.
Weak financial performance with a -37.97% YoY drop in net income and -97.35% YoY drop in EPS. Bearish technical indicators and lack of trading signals.
In Q3 2025, revenue remained at 0 with no growth. Net income dropped significantly to -$2,347,302 (-37.97% YoY), and EPS fell to -1.05 (-97.35% YoY). Gross margin remained at 0 with no improvement.
No analyst ratings or price target changes available.
